LabCorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the DCTs offering into global markets and help us meet your growing demand for patient-centric trial designs. The COVID-19 pandemic has increased sponsor interest and need for resilient DCT designs as sites restricted on-site visits, eliminating all but the most essential procedures. Moreover, the growing use of mobile health technologies as part of clinical research represents a new paradigm in patient-centric clinical research. Meeting patients where they are has become the new reality. With GlobalCare, we will be able to more effectively and efficiently reduce your costs while offering convenient, time-saving solutions for patients. Incorporation of GlobalCare services into our streamlines your vendor management and contracting process.
New Capabilities from Acquisition of GlobalCare Clinical Trials, LLC
GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs)